Moelis & Company LLC - Silihan lan utang jangka dawa perusahaan MC

Logo perusahaan publik Moelis & Company LLC (MC)

Moelis & Company (MC) wields significant influence in the M&A niche due to its unique expertise in complex debt restructuring. Despite geopolitical pressure, the consolidation of Western assets supports profitability. The company's long-term financial obligations demonstrate a current deleveraging trend, where the 0.25 indicator expresses the state of the metric. High deal bonuses allow the bank to attract top Wall Street experts.

Kewajiban jangka dawa perusahaan Moelis & Company (MC): kanggo periode 04.07.2022 - 31.10.2026
Sampel barang Moelis & Company

The specific nature of Moelis & Company (MC) in the M&A and restructuring sector requires high financial flexibility to retain key personnel. By analyzing the company's long-term debt, an investor assesses the total obligations with maturities exceeding one year, which allows for the differentiation of capital stability from temporary liquidity fluctuations and determines the business's real margin of safety before entering new deals.

Analisis pesaing Moelis & Company

Silihan lan utang jangka dawa perusahaan CTAS|TRI: Kewajiban jangka dawa perusahaan|Silihan lan utang jangka dawa perusahaan HLI (Houlihan Lokey Inc)|Booz Allen Hamilton Inc. (BAH) - Utang jangka dawa perusahaan|Utang jangka dawa Rentokil Initial Group (RTO)|Kewajiban jangka dawa perusahaan EXLS|Utang jangka dawa perusahaan pjtpartners.com|Kewajiban jangka dawa perusahaan FCN (FTI Consulting)|Gedhene kewajiban jangka dawa CNXC|Utang jangka dawa perusahaan Exponent Failure Analysis Associates EXPO|Gunggunge utang jangka dawa WNS Holdings (WNS)|CBZ - Utang jangka dawa perusahaan|Utang jangka dawa ABM Industries|TIC (Acuren) - Kewajiban jangka dawa perusahaan|LegalZoom.com (LZ) - Utang jangka dawa perusahaan|Utang jangka dawa perusahaan ICF International Inc|TASK: Silihan lan utang jangka dawa perusahaan|Utang jangka dawa perusahaan WLDN|Kewajiban jangka dawa perusahaan crai.com CRAI|Utang jangka dawa perusahaan TIXT (TELUS International (Cda) Inc.)|Gunggunge utang jangka dawa Deluxe Corp (DLX)|PHLT - Utang jangka dawa perusahaan|HCKT (Hackett Corp) - Tanggungan utang jangka dawa perusahaan|IBEX: Utang jangka dawa perusahaan|Tanggungan jangka dawa anpa.com.hk ANPA|Utang jangka dawa perusahaan Xerox Holdings Corporation|Kewajiban jangka dawa perusahaan Conduent Inc. (CNDT)|Utang jangka dawa perusahaan Kingsway Corp (KFS)|INV - Utang jangka dawa|Utang jangka dawa perusahaan LPRO (Open Lending)|RCM Technologies Inc. (RCMT) - Utang jangka dawa|TTEC - Utang jangka dawa perusahaan|RGP: Utang jangka dawa perusahaan|EGG: Utang jangka dawa perusahaan|TISI - Gunggunge utang jangka dawa|Utang jangka dawa perusahaan Primech Holdings|Issuer Direct Corporation (ACCS) - Gunggunge utang jangka dawa|Kewajiban jangka dawa perusahaan HHS (Harte Hanks)|RYOJ (ryojbaba.com) - Silihan lan utang jangka dawa perusahaan|SPPL - Tanggungan utang jangka dawa perusahaan|Gedhene kewajiban jangka dawa GRNQ (Greenpro Capital Corp)|WAI: Kewajiban jangka dawa perusahaan|Silihan lan utang jangka dawa perusahaan QH (Quhuo Limited)|PMAX: Utang jangka dawa perusahaan|Kewajiban jangka dawa perusahaan Lichen China Ltd|Utang jangka dawa perusahaan Bluemount Holdings Limited|Utang jangka dawa Zenta ZGM|Utang jangka dawa perusahaan Hang Feng Technology Innovation (FOFO)|Kewajiban jangka dawa perusahaan e-arc.com ARC|Utang jangka dawa perusahaan GSE Systems GVP|NVEE (NV5 Global) - Kewajiban jangka dawa|Performant Financial Corp - Utang jangka dawa perusahaan|STER - Utang jangka dawa perusahaan|tdcx.com (TDCX) - Utang jangka dawa perusahaan